3 unknown. 3 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Unknown 3 |
| Phase 3 | 2 | Unknown 2 |
Follow Dilatation, Pathologic: new trials by email Literature Review of Dilatation, Pathologic trials Research Report on Dilatation, Pathologic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| UVA-Riboflavin Crosslinking Treatment of Corneal Ectasia UV-X Light, Riboflavin - Keratoconus, Ectasia | Phase 2 | Unknown | Mercy Center for Corrective Eye Surgery | 250 | 2011-03-01 | 2011-03-29 |
| Collagen Cross-Linking for Keratoconus/Ectasia With and Without Intacs Riboflavin - Keratoconus, Ectasia | Phase 2 / Phase 3 | Unknown | Yaron S. Rabinowitz M.D. | 600 | 2009-01-21 | 2018-10-02 |
| Treatment of Keratoconus Using Collagen Cross-Linking Riboflavin-5-phosphate, Sham cross-linking - Keratoconus | Phase 2 / Phase 3 | Unknown | University at Buffalo | 150 | 2008-09-01 | 2009-02-11 |
Keratoconus (3) · Corneal Diseases (2) · Eye Diseases (1)
Pathological Conditions, Anatomical (3) · Pathological Conditions, Signs and Symptoms (3) · Eye Diseases (2) · Corneal Diseases (1)
Riboflavin (2) · Flavin Mononucleotide (1) · Lubricant Eye Drops (1)
Mercy Center for Corrective Eye Surgery (1) · University at Buffalo (1) · Yaron S. Rabinowitz M.D. (1)
United States (3)
Ezra Maguen, M.D. (1) · James J Reidy, M.D. (1) · James Salz, M.D. (1) · Robert L Epstein, MD (1) · Ronald Gaster, MD (1) · Yaron S Rabinowitz, M.D. (1) · Yuri Oleynikov, M.D. PhD (1)
PMID 16765803, PMID 16952090, PMID 12719068, PMID 16565005, PMID 16900027, PMID 17457183, PMID 17457184, PMID 17531694, PMID 17720054, PMID 18471635, PMID 18811118, PMID 20138607, PMID 20164744